Voyageur Pharmaceuticals Valuation
| VM Stock | CAD 0.05 0.01 9.09% |
Voyageur Pharmaceuticals seems to be fairly valued based on Macroaxis valuation methodology. Our model measures the value of Voyageur Pharmaceuticals from inspecting the company fundamentals such as Return On Equity of -0.96, shares outstanding of 138.81 M, and EBITDA of (1.34 M) as well as reviewing its technical indicators and probability of bankruptcy. In general, most investors recommend buying undervalued stocks and disposing overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other. Key fundamental drivers impacting Voyageur Pharmaceuticals' valuation include:
Price Book 6.2841 | Enterprise Value 7 M | Enterprise Value Ebitda (6.51) |
Fairly Valued
Today
Please note that Voyageur Pharmaceuticals' price fluctuation is out of control at this time. Calculation of the real value of Voyageur Pharmaceuticals is based on 3 months time horizon. Increasing Voyageur Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Voyageur Pharmaceuticals is useful when determining the fair value of the Voyageur stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Voyageur Pharmaceuticals. Since Voyageur Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Voyageur Stock. However, Voyageur Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.05 | Real 0.0494 | Hype 0.05 | Naive 0.0483 |
The real value of Voyageur Stock, also known as its intrinsic value, is the underlying worth of Voyageur Pharmaceuticals Company, which is reflected in its stock price. It is based on Voyageur Pharmaceuticals' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Voyageur Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Voyageur Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Voyageur Pharmaceuticals helps investors to forecast how Voyageur stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Voyageur Pharmaceuticals more accurately as focusing exclusively on Voyageur Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Voyageur Pharmaceuticals' intrinsic value based on its ongoing forecasts of Voyageur Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Voyageur Pharmaceuticals' closest peers. When choosing an evaluation method for Voyageur Pharmaceuticals, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Voyageur Pharmaceuticals Investments |
|
Voyageur Valuation Trend
Knowing Voyageur Pharmaceuticals' actual value is paramount for traders to make sound investment determinations. Voyageur Pharmaceuticals' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Voyageur Pharmaceuticals' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Voyageur Pharmaceuticals' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Voyageur Market Cap
Voyageur Pharmaceuticals is rated first in market capitalization category among related companies. Market capitalization of Health Care industry is at this time estimated at about 4.22 Billion. Voyageur Pharmaceuticals adds roughly 6.94 Million in market capitalization claiming only tiny portion of equities under Health Care industry.Voyageur Pharmaceuticals Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Voyageur Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Voyageur Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Voyageur Pharmaceuticals competition to find correlations between indicators driving Voyageur Pharmaceuticals's intrinsic value. More Info.Voyageur Pharmaceuticals is rated first in price to book category among related companies. It is rated first in beta category among related companies totaling about 0.08 of Beta per Price To Book. The ratio of Price To Book to Beta for Voyageur Pharmaceuticals is roughly 12.93 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Voyageur Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Voyageur Pharmaceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Voyageur Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Voyageur Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Voyageur Pharmaceuticals and how it compares across the competition.
About Voyageur Pharmaceuticals Valuation
The stock valuation mechanism determines the current worth of Voyageur Pharmaceuticals on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Voyageur Pharmaceuticals. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Voyageur Pharmaceuticals based exclusively on its fundamental and basic technical indicators. By analyzing Voyageur Pharmaceuticals's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Voyageur Pharmaceuticals's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Voyageur Pharmaceuticals. We calculate exposure to Voyageur Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Voyageur Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -2.5 K | -2.6 K | |
| Pretax Profit Margin | 0.00 | 0.00 | |
| Operating Profit Margin | 0.00 | 0.00 | |
| Net Profit Margin | 0.00 | 0.00 | |
| Gross Profit Margin | 0.00 | 0.00 |
8 Steps to conduct Voyageur Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Voyageur Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Voyageur Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Voyageur Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Voyageur Pharmaceuticals' revenue streams: Identify Voyageur Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Voyageur Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Voyageur Pharmaceuticals' growth potential: Evaluate Voyageur Pharmaceuticals' management, business model, and growth potential.
- Determine Voyageur Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Voyageur Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Voyageur Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Voyageur Stock analysis
When running Voyageur Pharmaceuticals' price analysis, check to measure Voyageur Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Voyageur Pharmaceuticals is operating at the current time. Most of Voyageur Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Voyageur Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Voyageur Pharmaceuticals' price. Additionally, you may evaluate how the addition of Voyageur Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |